Active ingredientDifloxacin HydrochlorideCat. No. P-D112-001CAS 91296-86-5Family · Pharmaceutical analytical standards
Difloxacin
A fluoroquinolone antibiotic for veterinary use only, approved in the United States in 1997 as tablets for dogs, for infections of the skin, soft tissues and urinary tract. This family brings together the active ingredient, pharmacopoeial impurities and labelled standards.
Did you know?Unlike other fluoroquinolones, only about 5% is cleared by the kidneys in dogs: the rest passes through the bile and is partly reabsorbed, which extends its stay in the body.
Go to the active ingredient →Active ingredientDifloxacin HydrochlorideCat. No. P-D112-001CAS 91296-86-5
Pharmacopoeial impurityDifloxacin EP Impurity GCat. No. P-D112-002CAS 98105-79-4
Isotopically labelledDifloxacin-d3 HClCat. No. P-D112-003CAS 1173021-89-0
Pharmacopoeial impurityDifloxacin EP Impurity ACat. No. P-D112-004
Pharmacopoeial impurityDifloxacin EP Impurity CCat. No. P-D112-005CAS 98106-19-5
Pharmacopoeial impurityDifloxacin EP Impurity DCat. No. P-D112-006CAS 265995-90-2
Pharmacopoeial impurityDifloxacin EP Impurity ECat. No. P-D112-007CAS 211236-46-3
Pharmacopoeial impurityDifloxacin EP Impurity FCat. No. P-D112-008No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceDifloxacin hydrochloride CRSEDQM code Y0001423Family DifloxacinImpurityDifloxacin impurity G CRSEDQM code Y0001429Family DifloxacinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.